Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(16):1119; doi:10.1093/jnci/djn297
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Hepatitis B Virus Genotypes and Mutants and Risk of HCC

The risk of hepatocellular carcinoma (HCC) increases with increasing serum level of hepatitis B virus (HBV). However, it is unclear whether HBV genotype and/or common variants in the precore and basal core promoter (BCP) regions of the HBV genome also contribute to the risk of HCC. Yang et al. (p. 1134) estimated the incidence of HCC in association with HBV genotype and precore and BCP mutants for 2762 Taiwanese men and women participated in a community-based cohort study with long-term follow-up. The participants were seropositive for HBV surface antigen but had not been diagnosed with HCC. HBV genotype C and the BCP A1762T/G1764A double mutant . . . [Full Text of this Article]

Prostatectomy vs Watchful Waiting: Extended Trial Follow-up

Breast Cancer Recurrence after Adjuvant Therapy

Treatment of Cancer-Related Fatigue

Antitumor Effects of Doxorubicin Followed by Zoledronic Acid

Incidence of Adenocarcinoma of the Esophagus Among Whites


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age
Linda Morris Brown, Susan S. Devesa, and Wong-Ho Chow
J Natl Cancer Inst 2008 100: 1184-1187. [Abstract] [Full Text] [PDF]

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
Abenaa M. Brewster, Gabriel N. Hortobagyi, Kristine R. Broglio, Shu-Wan Kau, Cesar A. Santa-Maria, Banu Arun, Aman U. Buzdar, Daniel J. Booser, Vincente Valero, Melissa Bondy, and Francisco J. Esteva
J Natl Cancer Inst 2008 100: 1179-1183. [Abstract] [Full Text] [PDF]

Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
Penelope D. Ottewell, Hannu Mönkkönen, Mark Jones, Diane V. Lefley, Robert E. Coleman, and Ingunn Holen
J Natl Cancer Inst 2008 100: 1167-1178. [Abstract] [Full Text] [PDF]

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Hwai-I Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Uchenna H. Iloeje, Chin-Lan Jen, Jun Su, Li-Yu Wang, Sheng-Nan Lu, San-Lin You, Ding-Shinn Chen, Yun-Fan Liaw, Chien-Jen Chen, and For the REVEAL-HBV Study Group
J Natl Cancer Inst 2008 100: 1134-1143. [Abstract] [Full Text] [PDF]

A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
Ollie Minton, Alison Richardson, Michael Sharpe, Matthew Hotopf, and Patrick Stone
J Natl Cancer Inst 2008 100: 1155-1166. [Abstract] [Full Text] [PDF]

Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
Anna Bill-Axelson, Lars Holmberg, Frej Filén, Mirja Ruutu, Hans Garmo, Christer Busch, Stig Nordling, Michael Häggman, Swen-Olof Andersson, Stefan Bratell, Anders Spångberg, Juni Palmgren, Hans-Olov Adami, Jan-Erik Johansson, and for the Scandinavian Prostate Cancer Group Study Number 4
J Natl Cancer Inst 2008 100: 1144-1154. [Abstract] [Full Text] [PDF]

SPCG-4: A Needed START to PIVOTal Data to Promote and ProtecT Evidence-Based Prostate Cancer Care
Timothy J. Wilt
J Natl Cancer Inst 2008 100: 1123-1125. [Extract] [Full Text] [PDF]

Hepatitis B Virus Genotype and Mutants: Risk Factors for Hepatocellular Carcinoma
Josep M. Llovet and Anna Lok
J Natl Cancer Inst 2008 100: 1121-1123. [Extract] [Full Text] [PDF]